Extract from the Register of European Patents

EP About this file: EP4084687

EP4084687 - COMPUTER-IMPLEMENTED DIABETES MANAGEMENT METHODS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.12.2025
Database last updated on 21.03.2026
FormerThe patent has been granted
Status updated on  26.12.2024
FormerGrant of patent is intended
Status updated on  10.09.2024
FormerRequest for examination was made
Status updated on  07.08.2024
FormerGrant of patent is intended
Status updated on  07.07.2024
FormerRequest for examination was made
Status updated on  07.10.2022
FormerThe international publication has been made
Status updated on  10.07.2021
Formerunknown
Status updated on  26.01.2021
Most recent event   Tooltip05.12.2025No opposition filed within time limitpublished on 07.01.2026  [2026/02]
Applicant(s)For:AL  CH  CY  CZ  ES  GB  GR  HR  HU  IE  IS  LI  MC  MK  NO  PL  RS  SK  SM  TR 
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
For:AT  BE  BG  DE  DK  EE  FI  FR  IT  LT  LU  LV  MT  NL  PT  RO  SE  SI 
Roche Diabetes Care GmbH
Sandhofer Strasse 116
68305 Mannheim / DE
[2025/02]
Former [2022/45]For:AL  AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MK  MT  NL  NO  PL  PT  RO  RS  SE  SI  SK  SM  TR 
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
For:DE 
Roche Diabetes Care GmbH
Sandhofer Strasse 116
68305 Mannheim / DE
Inventor(s)01 / KREY, David Christopher
c/o Roche Diabetes Care GmbH Sandhofer Strasse
116
68305 Mannheim / DE
02 / KUHR, Hans-Juergen
c/o Roche Diabetes Care GmbH Sandhofer Strasse
116
68305 Mannheim / DE
 [2022/45]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2022/45]
Application number, filing date20842147.923.12.2020
[2022/45]
WO2020US66746
Priority number, dateUS201962955338P30.12.2019         Original published format: US 201962955338 P
[2022/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021138171
Date:08.07.2021
Language:EN
[2021/27]
Type: A1 Application with search report 
No.:EP4084687
Date:09.11.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 08.07.2021 takes the place of the publication of the European patent application.
[2022/45]
Type: B1 Patent specification 
No.:EP4084687
Date:29.01.2025
Language:EN
[2025/05]
Search report(s)International search report - published on:EP08.07.2021
ClassificationIPC:A61B5/145, G16H20/10, G16H50/20, G16H50/30, A61B5/00
[2022/45]
CPC:
A61B5/14532 (EP,US); A61M5/1723 (US); A61B5/4839 (US);
A61B5/7275 (EP); A61M5/14244 (US); G16H20/17 (EP);
G16H40/63 (EP); G16H50/20 (EP); G16H50/30 (EP);
A61B2562/0295 (EP); A61B5/02055 (EP); A61B5/1118 (EP);
A61B5/6815 (EP); A61M2005/14208 (US); A61M2005/1726 (US);
A61M2205/502 (US); A61M2205/52 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/45]  
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:COMPUTERIMPLEMENTIERTE DIABETESVERWALTUNGSVERFAHREN[2022/45]
English:COMPUTER-IMPLEMENTED DIABETES MANAGEMENT METHODS[2022/45]
French:PROCÉDÉS DE GESTION DU DIABÈTE MIS EN OEUVRE PAR ORDINATEUR[2022/45]
Entry into regional phase24.03.2022National basic fee paid 
24.03.2022Designation fee(s) paid 
24.03.2022Examination fee paid 
Examination procedure24.03.2022Examination requested  [2022/45]
24.03.2022Date on which the examining division has become responsible
01.02.2023Amendment by applicant (claims and/or description)
08.07.2024Communication of intention to grant the patent
06.08.2024Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
11.09.2024Communication of intention to grant the patent
19.12.2024Fee for grant paid
19.12.2024Fee for publishing/printing paid
19.12.2024Receipt of the translation of the claim(s)
Opposition(s)30.10.2025No opposition filed within time limit [2026/02]
Fees paidRenewal fee
09.12.2022Renewal fee patent year 03
19.12.2023Renewal fee patent year 04
19.12.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ29.01.2025
HR29.01.2025
PL29.01.2025
SK29.01.2025
SM29.01.2025
NO29.04.2025
RS29.04.2025
GR30.04.2025
IS29.05.2025
[2025/49]
Former [2025/48]CZ29.01.2025
HR29.01.2025
PL29.01.2025
SM29.01.2025
NO29.04.2025
RS29.04.2025
GR30.04.2025
IS29.05.2025
Former [2025/46]HR29.01.2025
PL29.01.2025
SM29.01.2025
NO29.04.2025
RS29.04.2025
GR30.04.2025
IS29.05.2025
Former [2025/35]HR29.01.2025
PL29.01.2025
NO29.04.2025
RS29.04.2025
GR30.04.2025
IS29.05.2025
Former [2025/34]HR29.01.2025
PL29.01.2025
NO29.04.2025
RS29.04.2025
IS29.05.2025
Former [2025/33]PL29.01.2025
RS29.04.2025
Documents cited:Search[XI] WO2013023014  (SCHERB CLIFF et al.) [X] 1-2,5-8,10-13 * paragraphs [0010] , [0041] - [0048]; figure 1 *[I] 9,14
 [A] US2009069787  (ESTES MARK C et al.) [A] 1-2,4-14 * paragraphs [0082] - [0091] *
 [A] US2015217053  (BOOTH ROBERT C et al.) [A] 1,10-11 * abstract; figures 6a-6g *
 [X] US2011137141  (RAZOUMOV LEONID V et al.) [X] 1,7,9-12,14 * paragraphs [0027] - [0028] *
 [A] US9594354  (KAHN PHILIPPE RICHARD et al.) [A] 1,7,9-12,14 * column 3, paragraph 3 * * column 5, paragraph 4 *
International search[XI] WO2013023014  (SCHERB CLIFF et al.)
 [A] US2009069787  (ESTES MARK C et al.)
 [A] US2015217053  (BOOTH ROBERT C et al.)
 [X] US2011137141  (RAZOUMOV LEONID V et al.)
 [A] US9594354  (KAHN PHILIPPE RICHARD et al.)
by applicantUS6925393
 US9786024
 US10458973
 US10251583
 US2016287184
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.